Showing results (201-210 of 560) with videos related to
Sort By:
Pageof 56
Nephrology (Carlton, Vic.)|March 3, 2006
Race and sex: predictors of the severity of hyperparathyroidism in peritoneal dialysis patientsStanley L-S Fan, Anthony Chan, Martin J Raftery, et al.Electrophoresis|June 29, 2011
Monitoring cytoplasmic protein complexes with blue native gel electrophoresis and stable isotope labelling with amino acids in cell culture: analysis of changes in the 20S proteasomeTimothy A Couttas, Mark J Raftery, Melissa A Erce, et al.European Journal of Immunology|March 30, 2004
Frontline: Induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virusDagmar B Müller, Martin J Raftery, Angela Kather, et al.Kidney International|July 25, 2008
Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysisSanjeev Kumar, Stanley L-S Fan, Martin J Raftery, et al.Journal of the American Society of Nephrology : JASN|July 18, 2009
Bicarbonate supplementation slows progression of CKD and improves nutritional statusIone de Brito-Ashurst, Mira Varagunam, Martin J Raftery, et al.FEMS Microbiology Ecology|March 15, 2001
Feasibility of using GFP-expressing Escherichia coli, coupled with fluorimetry, to determine protozoan ingestion ratesJ D. Parry, K Heaton, J Drinkall, et al.Journal of Molecular Biology|February 7, 2002
Tissue-specific co-expression and in vitro heteropolymer formation of the two small branchiostoma intermediate filament proteins A3 and B2Anton Karabinos, Jürgen Schünemann, David A D Parry, et al.Molecular and Cellular Biology|January 16, 1999
Cyclin E associates with BAF155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrestF Shanahan, W Seghezzi, D Parry, et al.Advances in Protein Chemistry|December 28, 2006
Beta-structures in fibrous proteinsAndrey V Kajava, John M Squire, David A D ParryJournal of Medical Economics|May 25, 2010
Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient populationB Alemayehu, E Buysman, D Parry, et al.Pageof 56